AGÕæÈ˹ٷ½

STOCK TITAN

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
BriaCell Therapeutics Corp. (Nasdaq: BCTX), a clinical-stage biotechnology company focused on innovative cancer immunotherapies, has announced two upcoming virtual investor presentations. The events are scheduled for Thursday, June 12, and Thursday, June 26, 2025, both at 12:00 PM EDT. The presentations, organized by Renmark Financial Communications Inc., will be accessible to stakeholders, investors, and other interested parties through online registration. While live event participation may be limited, replays will be available on the Company's Investor website. Participants are advised to use the latest version of Google Chrome for optimal connectivity.
BriaCell Therapeutics Corp. (Nasdaq: BCTX), un'azienda biotecnologica in fase clinica specializzata in immunoterapie innovative contro il cancro, ha annunciato due prossime presentazioni virtuali per investitori. Gli eventi si terranno giovedì 12 giugno e giovedì 26 giugno 2025, entrambi alle 12:00 PM EDT. Le presentazioni, organizzate da Renmark Financial Communications Inc., saranno accessibili a stakeholder, investitori e altre parti interessate tramite registrazione online. La partecipazione in diretta potrebbe essere limitata, ma le registrazioni saranno disponibili sul sito web per gli investitori della Società. Si consiglia ai partecipanti di utilizzare l'ultima versione di Google Chrome per una connettività ottimale.
BriaCell Therapeutics Corp. (Nasdaq: BCTX), una empresa biotecnológica en etapa clínica centrada en inmunoterapias innovadoras contra el cáncer, ha anunciado dos próximas presentaciones virtuales para inversionistas. Los eventos están programados para el jueves 12 de junio y el jueves 26 de junio de 2025, ambos a las 12:00 PM EDT. Las presentaciones, organizadas por Renmark Financial Communications Inc., estarán disponibles para accionistas, inversionistas y otras partes interesadas mediante registro en línea. La participación en vivo puede ser limitada, pero las repeticiones estarán disponibles en el sitio web de inversores de la Compañía. Se recomienda a los participantes usar la última versión de Google Chrome para una conectividad óptima.
ìž„ìƒ ë‹¨ê³„ì� í˜ì‹ ì ì¸ ì•� 면역치료ì � 개발ì—� 주력하는 ìƒëª…공학 회사 브리아셀 í…Œë¼í“¨í‹±ìŠ� ì½”í¼ë ˆì´ì…�(Nasdaq: BCTX)ì€ ë‘� 차례ì� ê°€ìƒ� 투ìžìž� 프레젠테ì´ì…˜ì� 발표했습니다. 행사ëŠ� 2025ë…� 6ì›� 12ì� 목요ì¼ê³¼ 6ì›� 26ì� 목요ì�, ë‘� 차례 ëª¨ë‘ ì˜¤í›„ 12ì‹�(ë™ë¶€ 표준ì‹�)ì—� 예정ë˜ì–´ 있습니다. Renmark Financial Communications Inc.ê°€ 주최하는 ì´ë²ˆ 발표ëŠ� ì´í•´ê´€ê³„ìž, 투ìžìž� ë°� 기타 ê´€ì‹� 있는 분들ì� 온ë¼ì� 등ë¡ì� 통해 참여í•� ìˆ� 있습니다. 실시ê°� 참여ëŠ� 제한ë� ìˆ� 있으ë‚�, 녹화 ì˜ìƒì€ 회사 투ìžìž� 웹사ì´íЏì—서 제공ë� 예정입니ë‹�. ì›í™œí•� ì—°ê²°ì� 위해 최신 버전ì� 구글 í¬ë¡¬ 브ë¼ìš°ì € 사용ì� 권장합니ë‹�.
BriaCell Therapeutics Corp. (Nasdaq : BCTX), une société biotechnologique en phase clinique spécialisée dans les immunothérapies innovantes contre le cancer, a annoncé deux prochaines présentations virtuelles pour investisseurs. Les événements sont prévus le jeudi 12 juin et le jeudi 26 juin 2025, tous deux à 12h00 EDT. Organisées par Renmark Financial Communications Inc., ces présentations seront accessibles aux parties prenantes, investisseurs et autres intéressés via une inscription en ligne. La participation en direct peut être limitée, mais les rediffusions seront disponibles sur le site web investisseurs de la Société. Il est conseillé aux participants d'utiliser la dernière version de Google Chrome pour une connectivité optimale.
BriaCell Therapeutics Corp. (Nasdaq: BCTX), ein biotechnologisches Unternehmen in der klinischen Entwicklungsphase mit Fokus auf innovative Krebsimmuntherapien, hat zwei bevorstehende virtuelle Investorenpräsentationen angekündigt. Die Veranstaltungen sind für Donnerstag, den 12. Juni, und Donnerstag, den 26. Juni 2025, jeweils um 12:00 Uhr EDT geplant. Die Präsentationen, organisiert von Renmark Financial Communications Inc., sind für Stakeholder, Investoren und andere Interessierte nach Online-Registrierung zugänglich. Die Live-Teilnahme könnte begrenzt sein, aber Wiederholungen werden auf der Investorenseite des Unternehmens verfügbar sein. Teilnehmer werden empfohlen, die neueste Version von Google Chrome für eine optimale Verbindung zu verwenden.
Positive
  • None.
Negative
  • None.

PHILADELPHIA and VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (�BriaCell� or the �Company�), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, announces today that the Company will be conducting two virtual investor presentations on Thursday, June 12, at 12:00 PM EDT and on Thursday, June 26, at 12:00 PM EDT, arranged by Renmark Financial Communications Inc. Briacell Therapeutics Corp. welcomes stakeholders, investors, and other individual followers to register and attend these live events.

Investors interested in participating in this event will need to register using the links below. As a reminder, registration for the live event may be limited but access to the replay after the event will be on the Company’s Investor website.

REGISTER HERE:

To ensure smooth connectivity, please access this link using the latest version of Google Chrome.

About BriaCell Therapeutics Corp.

BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. More information is available at .

Safe Harbor

This press release contains “forward-looking statementsâ€� that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements may be identified by the use of words such as “anticipate,â€� “believe,â€� “contemplate,â€� “could,â€� “estimate,â€� “expect,â€� “intend,â€� “seek,â€� “may,â€� “might,â€� “plan,â€� “potential,â€� “predict,â€� “project,â€� “target,â€� “aim,â€� “should,â€� “will,â€� “would,â€� or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements, including those specifying the date and time that the Company will be conducting the virtual investor presentations, are based on BriaCell’s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully under the heading “Risks and Uncertaintiesâ€� in the Company’s most recent Management’s Discussion and Analysis, under the heading “Risk Factorsâ€� in the Company’s most recent Annual Information Form, and under “Risks and Uncertaintiesâ€� in the Company’s other filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, all of which are available under the Company’s profiles on SEDAR+ at Ìýand on EDGAR at . Forward-looking statements contained in this announcement are made as of this date, and BriaCell Therapeutics Corp. undertakes no duty to update such information except as required under applicable law.

Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

Company Contact:
William V. Williams, MD
President & CEO
1-888-485-6340
Ìý

Investor Relations Contact:


FAQ

When are BriaCell's (BCTX) upcoming virtual investor presentations in June 2025?

BriaCell has scheduled two virtual investor presentations on Thursday, June 12, 2025, and Thursday, June 26, 2025, both at 12:00 PM EDT.

How can investors attend BriaCell's (BCTX) virtual presentations in June 2025?

Investors need to register online for the events. While live participation may be limited, replays will be available on BriaCell's Investor website.

What is BriaCell Therapeutics (BCTX) main business focus?

BriaCell Therapeutics is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care.

Which stock exchanges is BriaCell (BCTX) listed on?

BriaCell is listed on the Nasdaq (under symbols BCTX, BCTXW, BCTXZ) and the Toronto Stock Exchange (under symbol BCT).
Briacell Therapeutics Corp

NASDAQ:BCTXZ

BCTXZ Rankings

BCTXZ Latest News

BCTXZ Latest SEC Filings

BCTXZ Stock Data

2.33M
Pharmaceutical Preparations
WEST VANCOUVER